JPS56110679A - 55aminootetrazole derivative of retinoic acid* its manufacture and medicine containing it - Google Patents

55aminootetrazole derivative of retinoic acid* its manufacture and medicine containing it

Info

Publication number
JPS56110679A
JPS56110679A JP913381A JP913381A JPS56110679A JP S56110679 A JPS56110679 A JP S56110679A JP 913381 A JP913381 A JP 913381A JP 913381 A JP913381 A JP 913381A JP S56110679 A JPS56110679 A JP S56110679A
Authority
JP
Japan
Prior art keywords
derivative
manufacture
retinoic acid
medicine containing
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP913381A
Other languages
English (en)
Inventor
Furitsuker Furitsutsuufuriidaa
Niyurenbatsuha Akuseru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of JPS56110679A publication Critical patent/JPS56110679A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP913381A 1980-01-25 1981-01-26 55aminootetrazole derivative of retinoic acid* its manufacture and medicine containing it Pending JPS56110679A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803002545 DE3002545A1 (de) 1980-01-25 1980-01-25 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
JPS56110679A true JPS56110679A (en) 1981-09-01

Family

ID=6092865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP913381A Pending JPS56110679A (en) 1980-01-25 1981-01-26 55aminootetrazole derivative of retinoic acid* its manufacture and medicine containing it

Country Status (9)

Country Link
US (1) US4459404A (ja)
EP (1) EP0033095B1 (ja)
JP (1) JPS56110679A (ja)
AT (1) ATE5073T1 (ja)
CA (1) CA1161044A (ja)
DE (2) DE3002545A1 (ja)
DK (1) DK30581A (ja)
IE (1) IE50767B1 (ja)
ZA (1) ZA81473B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757140A (en) * 1986-06-02 1988-07-12 Wisconsin Alumni Research Foundation Coenzyme a derivatives of all-trans- and 13-cis retionic acid
US4748183A (en) * 1986-06-13 1988-05-31 Warner-Lambert Company N-1H-tetrazol-5-yl-2-thiophene carboxamides, N-1H-tetrazol-5-yl-2-pyrrole carboxamides, N-1H-tetrazol-5-yl-2-furan carboxamides, and anti-allergic and anti-inflammatory use thereof
CA2063576C (en) 1989-06-07 1994-01-25 Gail S. Bazzano Slow release vehicles for minimizing skin irritancy of topical compositions
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
US5880292A (en) * 1997-09-11 1999-03-09 Wisconsin Alumni Research Foundation All-trans-retinol metabolite
SE0101702D0 (sv) * 2001-05-15 2001-05-15 Ardenia Investments Ltd Novel potentiating compounds
MX2018006894A (es) * 2015-12-09 2018-11-09 Ardenia Investments Ltd Metodo para producir alquil ester de acido n-retinoilcisteico.
GB201602572D0 (en) 2016-02-12 2016-03-30 Eriksson Leif And Strid Ake And Sirsjö Allan New compound and uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3256248A (en) * 1963-02-04 1966-06-14 Dow Chemical Co Vinyl n-heterocyclic amines and polymers thereof
US3950418A (en) * 1970-02-02 1976-04-13 Hoffmann-La Roche Inc. Vitamin A acid amides
CH529742A (de) * 1970-02-02 1972-10-31 Hoffmann La Roche Verfahren zur Herstellung von Vitamin-A-Säureamiden
DE2300107C2 (de) * 1973-01-03 1982-03-11 Basf Ag, 6700 Ludwigshafen Vitamin A-Säureanilid-4-carbonsäureäthylester, Verfahren zu seiner Herstellung und diesen enthaltende Zubereitungen
US4108880A (en) * 1975-11-03 1978-08-22 Johnson & Johnson Esters of retinoic acid
DE2843811A1 (de) * 1978-10-07 1980-04-24 Basf Ag Retinsaeure- und 7,8-dehydro-retinsaeure-n-(carboxy)-phenylamide

Also Published As

Publication number Publication date
ZA81473B (en) 1982-03-31
DE3002545A1 (de) 1981-07-30
US4459404A (en) 1984-07-10
IE810123L (en) 1981-07-25
ATE5073T1 (de) 1983-11-15
DE3161193D1 (en) 1983-11-24
EP0033095B1 (de) 1983-10-19
DK30581A (da) 1981-07-26
IE50767B1 (en) 1986-07-09
EP0033095A1 (de) 1981-08-05
CA1161044A (en) 1984-01-24

Similar Documents

Publication Publication Date Title
ZA885192B (en) Pharmaceutical preparations
HUT54144A (en) Process for producing 3-desmethylmevalonic acid derivatives and pharmaceutical compositions comprising same as active ingredient
JPS56110679A (en) 55aminootetrazole derivative of retinoic acid* its manufacture and medicine containing it
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
CA2002472A1 (en) Liquid oral formulation
DE3371515D1 (en) Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
ZA806282B (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters,their preparation,and pharmaceutical formulations containing these compounds
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
DE3065087D1 (en) Piperidine derivatives of 3-hydroxy-thiophene-2-carboxylic acid esters, their preparation, and pharmaceutical preparations containing them
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
IT1226144B (it) Di estere fosforico dell'acido ursodeossicolico e suoi derivati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principi attivi.